Real-time enrollment status for this intracerebral hemorrhage clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:44 PM UTC
| NCT Number | NCT07227246 |
| Recruiting Status | Recruiting |
| Condition | Intracerebral Hemorrhage |
| Phase | PHASE3 |
| Target Enrollment | 350 participants |
| Active Locations | 49 sites in the US |
| Sponsor | Joseph Broderick, MD |
| Last Updated on CT.gov | August 20, 2026 (Aug 20, 2026) |
As of October 12, 2026: Clinical trial NCT07227246 is currently recruiting participants. This phase3 study for intracerebral hemorrhage is actively seeking new participants at 49 locations across the United States. The study is sponsored by Joseph Broderick, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227246 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 49 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227246 was last updated Aug 20, 2026 (August 20, 2026). HelloStudys verifies this status automatically.